Efficacy and Safety of a Single-Pill Combination of Vildagliptin and Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Trial

INTRODUCTION: The use of dipeptidyl peptidase-4 inhibitors in combination with metformin is increasing in Japanese patients with type 2 diabetes mellitus (T2DM), but no single-pill combination (SPC) is currently available in Japan. The objective of this study was to assess the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Odawara, Masato, Yoshiki, Mika, Sano, Misako, Hamada, Izumi, Lukashevich, Valentina, Kothny, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374075/
https://www.ncbi.nlm.nih.gov/pubmed/25691359
http://dx.doi.org/10.1007/s13300-015-0099-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374075/
https://www.ncbi.nlm.nih.gov/pubmed/25691359
http://dx.doi.org/10.1007/s13300-015-0099-x

Ejemplares similares